- |||||||||| Biomarker, Journal: Comprehensive analysis of immunocyte infiltration and the key genes associated with intraplaque hemorrhage in carotid atherosclerotic plaques. (Pubmed Central) - Apr 7, 2022
The hub genes, mRNA-miRNA-lncRNA axes, and signaling pathways related to RA pathogenesis identified in this study provide a new research direction for the mechanism, diagnosis, and treatment of RA. Eight genes were found to be involved in IPH, and four genes (ITGB2, VAV1, ITGAM, TYROBP) may be an important biomarkers for IPH.
- |||||||||| In vivo programming of myeloid cells by mRNA mediated delivery of novel Fc alpha fusion receptor activates anti-tumor immunity (Section 17) - Mar 9, 2022 - Abstract #AACR2022AACR_2335;
Furthermore, in the B16 syngeneic melanoma model, treatment with the melanoma antigen GP75 targeted Fc-alpha Receptor Fusion Constructs was also associated with the initiation of broad systemic immune responses, characterized by tumoral accumulation of activated CD8+ T cells, reduced tumor associated Tregs and activation of antigen presenting cells in spleen. Together these studies highlight the potential of Fc-alpha Receptor Fusion Construct delivered directly in vivo to program myeloid cells to recognize and kill cancer.
- |||||||||| Journal, Gene Signature, IO biomarker: A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma. (Pubmed Central) - Feb 5, 2022
The novel immune-related prognostic signature we constructed has a good prognostic, predictive ability and can be used as an independent prognostic indicator. Our study provides clinicians with a quantitative tool to predict the probability of individual survival time and helps clinicians select targets for immunotherapies and individualized treatment strategies for ESCC patients.
- |||||||||| Journal: Atlas of genetic effects in human microglia transcriptome across brain regions, aging and disease pathologies. (Pubmed Central) - Feb 4, 2022
Our study provides clinicians with a quantitative tool to predict the probability of individual survival time and helps clinicians select targets for immunotherapies and individualized treatment strategies for ESCC patients. In summary, we have built the most comprehensive catalog to date of genetic effects on the microglia transcriptome and propose molecular mechanisms of action of candidate functional variants in several neurological and neuropsychiatric diseases.
- |||||||||| dexamethasone / Generic mfg.
Journal, IO biomarker: The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis. (Pubmed Central) - Sep 19, 2021 Immune genes such as SRC, RHOA, CD40LG, CSF1, TNFRSF1A, FCER1G, ICAM1, LAT, LCN2, PLAU, CXCL10, ICAM1, CD40, IRF7, and B2M were predicted to be the hub genes in the cytokine storm. Furthermore, we inferred that resveratrol, acetaminophen, dexamethasone, estradiol, statins, curcumin, and other compounds are potential target drugs in the treatment of COVID-19.
- |||||||||| MK-0752 / Merck (MSD), volasertib (BI 6727) / Oncoheroes
Journal: PLK1 and NOTCH Positively Correlate in Melanoma and their Combined Inhibition Results in Synergistic Modulations of Key Melanoma Pathways. (Pubmed Central) - Aug 14, 2021 We identified the modulations of several key genes relevant to melanoma progression/metastasis, including MAPK, PI3K, and RAS, as well as some new genes such as Apobec3G, BTK and FCER1G which have not been well-studied in melanoma. In conclusion, our study demonstrated a synergistic anti-proliferative response of a concomitant targeting of PLK1 and NOTCH in melanoma, unraveling a potential novel therapeutic approach for detailed preclinical/clinical evaluation.
- |||||||||| [VIRTUAL] Profiling microglial nodules in MS: possible implications for MS lesion formation (Stream 4 Pathogenesis) - Aug 3, 2021 - Abstract #ECTRIMS2021ECTRIMS_1317;
In MS tissue, the number of HLA-DR+ nodules was higher compared to stroke tissue (p<0.05). In MS nodules vs MS peri-nodular tissue, 325 differentially expressed (DE) genes were upregulated, involved in immune response (FCGR3A, IRF8, TNFSF13B, CD276, MHC class II, FCER1G), phagocytosis (AXL, CD13, SLC11A1), and nitric oxide metabolism (TLR2, TLR6).
- |||||||||| Atlas of genetic effects in human microglia transcriptome across brain regions, aging and disease pathologies (Convention Ctr - 601/603) - Aug 2, 2021 - Abstract #AAIC2021AAIC_1510;
In MS nodules vs MS peri-nodular tissue, 325 differentially expressed (DE) genes were upregulated, involved in immune response (FCGR3A, IRF8, TNFSF13B, CD276, MHC class II, FCER1G), phagocytosis (AXL, CD13, SLC11A1), and nitric oxide metabolism (TLR2, TLR6). In summary, we have built the most comprehensive catalog to date of genetic effects on the microglia transcriptome and propose molecular mechanisms of action of candidate functional variants in several neurological and neuropsychiatric diseases.
- |||||||||| Journal: Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology. (Pubmed Central) - Jul 30, 2021
Single microglia sequencing confirms that Aβ, not TAU, pathology induces marked transcriptional changes in microglia, including increased proportions of activated microglia. We conclude that genetic risk of AD functionally translates into different microglia pathway responses to Aβ pathology, placing AD genetic risk downstream of the amyloid pathway but upstream of TAU pathology.
- |||||||||| Clinical, Journal: Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis. (Pubmed Central) - Jul 7, 2021
The predictive value of the prognostic model including TFF3, EPDR1, MACROD1, ARHGEF12, AMMECR1, NFATC2, HES6, PLEK2 and SNCA was identified, and validated in another external dataset (MMRF-CoMMpass cohort from TCGA). In conclusion, this study provides reliable molecular biomarkers for screening, prognosis, as well as novel therapeutic targets for myeloma LC/SP cells.
- |||||||||| Journal: Key genes associated with non-alcoholic fatty liver disease and acute myocardial infarction. (Pubmed Central) - Apr 29, 2021
RESULTS To obtain the pathogenesis associated with both NAFLD and AMI, protein-protein interaction (PPI) network was constructed and the top ten hub genes (TLR2, LILRB2, CXCL1, FPR1, TLR4, TYROBP, MMP9, FCER1G, CLEC4D and CCR2) were selected with CONCLUSIONS The results of this study suggesting some novel genes may play an important role in the occurrence and progression NAFLD and AMI. But more experimental researches and clinical trials need to verify.
|